B

Berclaz, Luc M.; Burkhard-Meier, Anton; Lechner, Axel; Völkl, Michael; Güler, Sinan E.; Abdel-Rahman, Sultan; Mansoorian, Sina; Kunz, Wolfgang G.; Knösel, Thomas; Canis, Martin; von Bergwelt-Baildon, Michael; Issels, Rolf D.; Di Gioia, Dorit; Lindner, Lars H. (2025): Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma. Cancer Immunology, Immunotherapy, 74: 174. ISSN 1432-0851

Berclaz, Luc M.; Di Gioia, Dorit; Jurinovic, Vindi; Völkl, Michael; Güler, Sinan E.; Albertsmeier, Markus; Klein, Alexander; Dürr, Hans Roland; Mansoorian, Sina; Knösel, Thomas; Kunz, Wolfgang G.; von Bergwelt-Baildon, Michael; Lindner, Lars H.; Burkhard-Meier, Anton (2025): LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. BMC Cancer, 25: 496. ISSN 1471-2407

Berclaz, Luc M.; Di Gioia, Dorit; Völkl, Michael; Jurinovic, Vindi; Klein, Alexander; Dürr, Hans Roland; Knösel, Thomas; Teodorescu, Bianca; Enßle, Stefan; Rippl, Michaela; Bergwelt-Baildon, Michael von; Kunz, Wolfgang G.; Lindner, Lars H.; Burkhard-Meier, Anton (2025): The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma. BMC Cancer, 25: 671. ISSN 1471-2407

Berclaz, Luc M. ORCID: 0000-0003-4405-138X; Jurinovic, Vindi; Burkhard‐Meier, Anton; Abdel‐Rahman, Sultan; Albertsmeier, Markus; Klein, Alexander; Dürr, Hans Roland; Schmidt‐Hegemann, Nina‐Sophie; Knösel, Thomas; Kunz, Wolfgang G.; Stutz, Emanuel; Bergwelt‐Baildon, Michael von; Di Gioia, Dorit; Lindner, Lars H. (2025): Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis. Cancer Medicine, 14 (4): e70655. ISSN 2045-7634

Boukovala, M.; Modest, D.P.; Ricard, I.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Uhlig, J.; Schenk, M.; Freiberg-Richter, J.; Peuser, B.; Denzlinger, C.; Peveling Genannt Reddemann, C.; Graeven, U.; Schuch, G.; Schwaner, I.; Heinrich, K.; Neumann, J.; Jung, A.; Held, S.; Stintzing, S.; Heinemann, V.; Michl, M. (2024): Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110). ESMO Open, 9 (5): 103374. ISSN 20597029

Burkhard-Meier, Anton; Di Gioia, Dorit; Jurinovic, Vindi; Hoberger, Michael; Güler, Sinan E.; Völkl, Michael; Corradini, Stefanie; Gaasch, Aurélie V.; Alig, Annabel H. S.; Knösel, Thomas; Hagl, Christian; Schneider, Christian; Sienel, Wulf; Kunz, Wolfgang G.; Burkhard-Meier, Caspar; von Bergwelt-Baildon, Michael; Lindner, Lars H.; Berclaz, Luc M. (2025): Primary cardiac sarcoma: insights from two decades of multimodal management at LMU Munich. Cardio-Oncology, 11: 58. ISSN 2057-3804

Burkhard-Meier, Anton; Rechenauer, Vera Valerie; Jurinovic, Vindi; Albertsmeier, Markus; Hoberger, Michael; Dürr, Hans Roland; Klein, Alexander; Knösel, Thomas; Kunz, Wolfgang G.; Mock, Andreas; Pusztai, Ada; Völkl, Michael; von Bergwelt-Baildon, Michael; Lindner, Lars H.; Di Gioia, Dorit; Berclaz, Luc M. (2025): First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. Journal of Cancer Research and Clinical Oncology, 151: 150. ISSN 1432-1335

C

Cordas dos Santos, David M.; Liu, Lian; Gerisch, Melvin; Hellmuth, Johannes C.; von Bergwelt-Baildon, Michael; Kunz, Wolfgang G.; Theurich, Sebastian (2022): Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index—Based Prediction of COVID-19-Associated Respiratory Failure. Nutrients, 14 (20): 4280. ISSN 2072-6643

D

Dempke, Wolfram C. M.; Fenchel, Klaus (2025): TET2 cascade: a novel regulator of chromatin structure and leukaemogenesis. Signal Transduction and Targeted Therapy, 10: 6. ISSN 2059-3635

H

Haebe, Sarah; Fraccaroli, Alessia; Stauffer, Elena; Prevalsek, Dusan; Zoellner, Anna; Drolle, Heidrun; Stemmler, Hans-Joachim; Dreyling, Martin; Bergwelt-Baildon, Michael von; Tischer, Johanna (2023): PTCY-Based Haploidentical Donor Transplantation versus HLA-Matched Related and Unrelated Donor Transplantations in Patients with Refractory or Relapsed Lymphoma—A Matched-Pair Analysis. Cancers, 15. ISSN 2072-6694

Haebe, Sarah; Schuebbe, Gesa; Jurmeister, Philipp; von Bergwelt-Baildon, Michael; Westphalen, C. Benedikt; Lauer, Ulrich M.; Kunz, Wolfgang G.; Subklewe, Marion; Weigert, Oliver (2025): Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients. npj Precision Oncology, 9: 26. ISSN 2397-768X

K

Khatamzas, Elham ORCID: 0000-0001-9253-1340; Antwerpen, Markus H. ORCID: 0000-0003-4013-8808; Rehn, Alexandra; Graf, Alexander; Hellmuth, Johannes Christian; Hollaus, Alexandra; Mohr, Anne-Wiebe; Gaitzsch, Erik; Weiglein, Tobias; Georgi, Enrico; Scherer, Clemens; Stecher, Stephanie-Susanne ORCID: 0000-0001-6715-1020; Gruetzner, Stefanie; Blum, Helmut; Krebs, Stefan; Reischer, Anna; Leutbecher, Alexandra; Subklewe, Marion; Dick, Andrea; Zange, Sabine; Girl, Philipp; Müller, Katharina; Weigert, Oliver; Hopfner, Karl-Peter ORCID: 0000-0002-4528-8357; Stemmler, Hans-Joachim; Bergwelt-Baildon, Michael von; Keppler, Oliver T. ORCID: 0000-0002-1384-8946; Wölfel, Roman; Muenchhoff, Maximilian; Moosmann, Andreas (2022): Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection. Nature Communications, 13: 5586. ISSN 2041-1723

Knabe, Ricarda; Muller, Philippe ORCID: 0009-0000-0985-7666; Schliemann, Christoph ORCID: 0000-0003-1755-9583; Hanoun, Maher ORCID: 0000-0002-1754-8940; Unglaub, Julia Marie ORCID: 0000-0002-3577-5493; Weinbergerová, Barbora ORCID: 0000-0001-6460-2471; Mayer, Jiri; Krekeler, Carolin ORCID: 0009-0000-1808-5928; Krause, Stefan W ORCID: 0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: 0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: 0000-0002-5897-3310; Subklewe, Marion ORCID: 0000-0001-9154-9469; Bücklein, Veit L. ORCID: 0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: 0000-0002-5021-1952; Rudelius, Martina ORCID: 0000-0001-6928-9955; von Bergwelt-Baildon, Michael ORCID: 0000-0002-1952-052X; Gutmair, Katja ORCID: 0009-0002-3948-6186; Hoster, Eva ORCID: 0000-0002-0749-1389; Herold, Tobias ORCID: 0000-0002-9615-9432; Röllig, Christoph ORCID: 0000-0002-3791-0548; Spiekermann, Karsten ORCID: 0000-0002-5139-4957 (2025): Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups. Blood Advances. ISSN 2473-9529

Köhnke, Thomas; Liu, Xilong; Haubner, Sascha; Bücklein, Veit; Hänel, Gerulf; Krupka, Christina; Solis-Mezarino, Victor; Herzog, Franz; Subklewe, Marion (2022): Integrated multiomic approach for identification of novel immunotherapeutic targets in AML. Biomarker Research, 10: 43. ISSN 2050-7771

R

Reischer, Anna; Leutbecher, Alexandra; Hiller, Björn; Perini, Enrico; White, Kieron; Hernández-Cáceres, Alejandra; Schele, Alexandra; Tast, Benjamin; Rohrbacher, Lisa; Winter, Lis; Czogalla, Bastian; Mahner, Sven; Flaswinkel, Heinrich; Leonhardt, Heinrich; Wyder, Lorenza; Wichmann, Christian; Maenner, Denis; Trillsch, Fabian; Kessler, Mirjana; Hopfner, Karl-Peter; Fenn, Nadja C.; Subklewe, Marion (2025): Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy. Cancer Immunology, Immunotherapy, 74: 214. ISSN 1432-0851

Rejeski, Kai; Hansen, Doris K.; Bansal, Radhika; Sesques, Pierre; Ailawadhi, Sikander; Logue, Jennifer M.; Bräunlein, Eva; Cordas dos Santos, David M.; Freeman, Ciara L.; Alsina, Melissa; Theurich, Sebastian; Wang, Yucai; Krackhardt, Angela M.; Locke, Frederick L.; Bachy, Emmanuel; Jain, Michael D.; Lin, Yi; Subklewe, Marion (2023): The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. Journal of Hematology & Oncology, 16 (88). ISSN 1756-8722

Resuli, Blerina; Galarza, Heidi; Kauffmann-Guerrero, Diego; Oversohl, Julian; Behr, Jürgen; Tufman, Amanda (2025): Safety and efficacy of the combination of selpercatinib with osimertinib in NSCLC: a case report and review of the literature. Frontiers in Oncology, 15: 1580322. ISSN 2234-943X

S

Stock, Sophia; Bücklein, Veit L.; Blumenberg, Viktoria; Magno, Giulia; Emhardt, Alica‐Joana; Holzem, Alessandra M. E.; Cordas dos Santos, David M.; Schmidt, Christian; Grießhammer, Stefanie; Frölich, Lisa; Kobold, Sebastian; von Bergwelt‐Baildon, Michael; Rejeski, Kai ORCID: 0000-0003-3905-0251; Subklewe, Marion (2025): Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma. HemaSphere, 9 (1): e70062. ISSN 2572-9241

Stock, Sophia; Fertig, Luisa; Gottschlich, Adrian; Dörr, Janina; Märkl, Florian; Majed, Lina; Menkhoff, Vivien D.; Grünmeier, Ruth; Rejeski, Kai; Cordas dos Santos, David M.; Theurich, Sebastian; von Bergwelt-Baildon, Michael; Endres, Stefan; Subklewe, Marion; Kobold, Sebastian (2024): Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma. Cancer Immunology, Immunotherapy, 73 (6). ISSN 1432-0851